ORMP — Oramed Pharmaceuticals Inc. - Common Stock (ORMP)
Every disclosed congressional transaction in this security, both parties, every chamber. Each row links to the filing it came from.
These are legally required disclosures, not allegations — timing can be coincidence.
Who trades it, and which way
By party
Democrats 0 Republicans 4
By direction
Purchases 1 Sales 3
Inside its sector Pharmaceuticals & Biotech
Congressional transactions per security in this sector — the page you are on is highlighted.
Plus 1,067 transactions across the sector's other securities.
Follow the federal money
Why a company's stock can be sensitive to what Congress does: many of them are also paid by the government. Oramed Pharmaceuticals Inc.'s federal contracts, grants and loans are public record.
Look up Oramed Pharmaceuticals Inc. on USASpending →
We link to the source rather than repeat a dollar figure here. Federal awards are recorded under many recipient names — a parent company and its subsidiaries — so an accurate company-wide total has to be read at USASpending itself, where the recipient hierarchy is resolved. Present this beside the trading record and draw your own conclusions.
Transactions
| Date | Member | Action | Amount (as filed) | Owner | Filing |
|---|---|---|---|---|---|
| 2025-01-10 | Brad Knott R-NC | sell | $15,001 – $50,000 | self | record |
| 2022-01-14 | Andrew R. Garbarino R-NY | sell | $1,001 – $15,000 | self | record |
| 2021-10-01 | Andrew R. Garbarino R-NY | sell | $1,001 – $15,000 | self | record |
| 2021-04-23 | Andrew R. Garbarino R-NY | buy | $1,001 – $15,000 | self | record |
Prices are market data (split- and dividend-adjusted closes), used only for context — every disclosure fact on this page comes from the filings linked in the table above. See Methodology.